Tilray Stock Has Shown Lots of Progress, but the Valuation I

Tilray Stock Has Shown Lots of Progress, but the Valuation Is Frothy
InvestorPlace
2/22/2021
Ahead of its earnings report,
Tilray (NASDAQ:
TLRY) came under some pressure. Note that TLRY stock fell about 9% or so. Then again, many other cannabis stocks fell as well.
© Provided by InvestorPlace
marijuana stocks Hand gently holding rich soil for his marijuana plants
But volatility is nothing new for Tilray. For the most part, Wall Street liked the performance for the quarter.
Revenues rose by 20.5% to $56.6 million, which compared to the Street consensus of $56 million. The company’s bottom line was also better than expected. The net loss was $2.9 million or 2 cents a share. As for the analysts’ consensus, it was for a net loss of 14 cents a share.

Related Keywords

Germany , Portugal , Canada , Spain , Canadian , Tilray Brendan Kennedy , Irwin Simon , , Jetacom Autofocus , Wall Street , Grow Pharma , Worldpharma Biotech , Brendan Kennedy , ஜெர்மனி , போர்சுகல் , கனடா , ஸ்பெயின் , கனடியன் , இர்வின் சிமோன் , சுவர் தெரு , வளர பார்மா , பிரெண்டன் கெந்நெடீ ,